Ravi Thadhani,S. Ananth Karumanchi,Eliyahu Khankin,Walter P. Mutter
申请号：
US13123841
公开号：
US20120020974A1
申请日:
2009.10.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The methods described herein can be used to identify ex ante which hemodialysis patients are likely to develop EPO resistance and therefore will require additional rHu EPO, and to provide treatments that can reduce the need for additional rHu EPO. In addition, the methods can be used to predict which subjects have a higher risk of mortality, to identify high-risk patients who can then be monitored more closely or treated more aggressively. Also provided are kits for carrying out the described methods.
